Loading profile...
Anita was appointed to the Board in January 2024. Anita is the CEO of Probi AB. Probi's foundation rests on science, leveraging state-of-the-art R&D and manufacturing expertise to create standout probiotic products that offer proven value. Anita is also currently serving as an elected Board member of the International Association of Probiotics (IPA) and on the Board of IPA Europe. Anita earned her Master of Pharmacy and her PhD degree in Pharmaceutical Technology from the Danish University of Pharmaceutical Sciences, University of Copenhagen. Throughout her career she has been working with product development and held leadership positions in global consumer healthcare companies, such as Ferrosan, Pfizer Consumer Healthcare, Novozymes, and USP Zdrowie. Anita joined Probi in April 2022 as the Vice President of Research & Development, and since April 2023 has been the Chief Executive Officer of Probi. Anita leads by creating and leading effective high performing teams and mentoring, inspiring and growing new talent. Anita is passionate about promoting the advantages of good bacteria by delivering customer relevant innovations supported by science.
Master of Pharmacy and PhD in Pharmaceutical Technology from the Danish University of Pharmaceutical Sciences, University of Copenhagen
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.